Human Medicines European Public Assessment Report (EPAR): Fexeric, Ferric Citrate Coordination Complex, Hyperphosphatemia,Renal Dialysis, Date of Authorisation: 23/09/2015, Revision: 2, Status: Authorised

Case Medical Research
doi 10.31525/cmr-1ecee1b
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Case Journals

Related search

Human Medicines European Public Assessment Report (EPAR): Ventavis, Iloprost, Hypertension, Pulmonary, Date of Authorisation: 15/09/2003, Revision: 26, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Ivabradine Anpharm, Ivabradine, Angina Pectoris,Heart Failure, Date of Authorisation: 08/09/2015, Revision: 4, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Intelence, Etravirine, HIV Infections, Date of Authorisation: 28/08/2008, Revision: 23, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Entecavir Mylan, Entecavir, Hepatitis B, Date of Authorisation: 18/09/2017, Revision: 1, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): NovoRapid, Insulin Aspart, Diabetes Mellitus, Date of Authorisation: 07/09/1999, Revision: 29, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Farydak, Panobinostat, Multiple Myeloma, Date of Authorisation: 28/08/2015, Revision: 6, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Lenvima, Lenvatinib, Thyroid Neoplasms, Date of Authorisation: 28/05/2015, Revision: 6, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Steglujan, Ertugliflozin / Sitagliptin, Diabetes Mellitus, Type 2, Date of Authorisation: 23/03/2018, Revision: 4, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Odomzo, Sonidegib, Carcinoma, Basal Cell, Date of Authorisation: 14/08/2015, Revision: 6, Status: Authorised

Case Medical Research
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy